Medicare nearly doubles payment for high-throughput diagnostic tests
Medicare will increase payment for certain "high-throughput" COVID-19 diagnostic tests to $100 to expand testing capacity and speed results during the public health emergency, the Centers for Medicare & Medicaid Services announced yesterday. The tests can process more than 200 specimens a day but require specially trained technicians and more time-intensive processes to assure quality. CMS expects the payment increase to allow laboratories to expand testing, particularly to vulnerable nursing home patients. Medicare administrative contractors previously paid about $51 for these clinical laboratory diagnostic tests under Medicare Part B.
Related News Articles
Headline
The American Medical Association Nov. 17 released its latest annual report on health insurance competition, which found that 95% of commercial markets were…
Headline
The Medicare Part A deductible for inpatient hospital services will increase by $40 in calendar year 2026 to $1,776, the Centers for Medicare & Medicaid…
Headline
The Centers for Medicare & Medicaid Services Nov. 16 issued a proposed rule on program integrity oversight in Medicare, Medicaid, the Children’s Health…
Headline
The Centers for Medicare & Medicaid Services Nov. 5 published a final rule to codify the Medicare Drug Price Negotiation Program beginning in 2029. The…
Headline
The estimated average monthly premium for Medicare Part D stand-alone prescription drug plans is $51 for 2027, a 50% increase from $34 in 2026, for enrollees…
Headline
The Centers for Medicare & Medicaid Services released a proposed rule Oct. 16 seeking to codify regulations that will improve the accuracy of Medicare…